This book provides a comprehensive and complete overview of biomarkers in clinical practice for
inflammatory bowel disease (IBD) bringing together the literature in a clear and concise
manner. The book bridges the gap between growing knowledge at the bench and current and future
applications of biomarkers in clinical practice. The central structure of the book focuses on
prognostic and predictive biomarkers in IBD with an emphasis on the fields of research and
scientific techniques (genomics proteomics and metabonomics) that have led to biomarker
discovery and places these biomarkers within a clinical context to help understand their
utility in clinical practice. This book will be of use to clinicians who have an interest in
using biomarkers in clinical practice as well as clinician researchers and scientists involved
in the biomarker research pipeline. The author team comprises experts from around the world in
order to bring together the literature in an effort to inform clinicians and researchers about
the current state-of-the art in biomarker discovery. It is intended to assist future research
efforts and indicate how biomarkers might be best applied to clinical practice both at present
and in the future.
